OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: Leukemia Research
DOI: 10.1016/j.leukres.2008.12.020
Authors: Arturo Vega-Ruiz, Jorge E. Cortes, Matjaz Sever, Taghi Manshouri, Alfonso Quintás-Cardama, Raja Luthra, Hagop M. Kantarjian, Srdan Verstovsek
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: Mast cells and histamine
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: imatinib mesylate, systemic mastocytosis, KIT inhibitors, complete remission, diarrhea, drug tolerability
SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2126677578
FWCI: 5.374
Cites: 11
Cited by: 166
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms